Boston Bio Systems Ltd
Boston Bio Systems Ltd (BOSTONBIO) last traded at ₹4.8, a market capitalisation of ₹3.37 crore. Over the past 52 weeks the stock has ranged between ₹4.01 and ₹11. Boston Bio Systems Ltd last reported results for the quarter ended Mar 2026, with sales of ₹0 crore and net profit of ₹-0.65 crore. Figures are as of 25 Aug 2026 and are not real time.
Boston Bio Systems Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Boston Bio Systems Ltd quarterly results
In the quarter ended Mar 2026, sales were ₹0 cr, down 100.0% from ₹0.19 cr a year earlier. Net profit was ₹-0.65 cr, down 32.7% year on year.
| ₹ crore | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0.19 | 0.18 | 0.24 | 0.06 | 0 |
| Expenses | 0 | 0.01 | 0.05 | 0.68 | 0.1 | 0.14 | 0.04 | 0.08 |
| Operating profit | 0 | -0.01 | -0.05 | -0.49 | 0.08 | 0.1 | 0.02 | -0.08 |
| OPM % | — | — | — | -257.89% | 44.44% | 41.67% | 33.33% | — |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0.03 | 0.05 | 0.03 | 0.59 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | -0.01 | -0.05 | -0.49 | 0.05 | 0.05 | -0.01 | -0.67 |
| Tax % | — | 0.00% | 0.00% | 0.00% | 20.00% | 20.00% | 0.00% | -4.48% |
| Net profit | 0 | -0.01 | -0.05 | -0.49 | 0.04 | 0.04 | -0.01 | -0.65 |
| EPS (₹) | 0.00 | -0.01 | -0.07 | -0.70 | 0.06 | 0.06 | -0.01 | -0.93 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Boston Bio Systems Ltd annual results
| ₹ crore | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 0.7 | 0 | 0 | 0 | 0.19 | 0.48 |
| Operating profit | 0 | 0 | 0 | -0.14 | -0.55 | 0.01 |
| OPM % | 0.00% | — | — | — | -289.47% | 2.08% |
| Net profit | 0 | 0 | 0 | -0.14 | -0.55 | -0.58 |
| EPS (₹) | 0.00 | 0.00 | 0.00 | -0.20 | -0.79 | -0.83 |
TTM is the trailing twelve months to the most recent quarter.
Boston Bio Systems Ltd growth and returns
- 10 Years
- -11%
- 5 Years
- %
- 3 Years
- %
- TTM
- 153%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -5%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- -43%
- 10 Years
- %
- 5 Years
- -4%
- 3 Years
- -7%
- Last Year
- -10%
Boston Bio Systems Ltd shareholding pattern
Promoters held 2.14% at Jun 2026, broadly unchanged since Jun 2025. DIIs 1.70%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% | 2.14% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.70% | 1.70% |
| Public | 97.86% | 97.86% | 97.85% | 97.85% | 97.86% | 97.85% | 96.14% | 96.15% |
| No. of shareholders | 1,141 | 1,141 | 1,147 | 1,295 | 1,385 | 1,410 | 1,408 | 1,447 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Boston Bio Systems Ltd corporate filings
- Intimation of cancellation of Board Meeting scheduled to be held on 21st August, 2026Company Updatelow impact
Cruxal's analysis: Boston Commerce Limited has announced the cancellation of its board meeting originally…
Read the full analysis - Intimation of Resignation of Secretarial AuditorCompany Updatelow impact
Cruxal's analysis: Boston Commerce Limited has formally notified the exchange regarding the resignation of…
Read the full analysis - Intimation of Appointment of Mrs. Archana Chaitanya Pandya as Additional Director in the capacity of Whole Time Director and Chief Financial Officer (CFO)Company Updatelow impact
Cruxal's analysis: Boston Commerce Limited has announced the appointment of Mrs. Archana Chaitanya Pandya as…
Read the full analysis - Outcome of Board Meeting held on 14th August, 2026Board Meetingmedium impact
Cruxal's analysis: Boston Commerce Limited has reported a significant leadership transition, including the…
Read the full analysis - Intimation of change in management.Company Updatehigh impact
Cruxal's analysis: Boston Commerce Limited has announced the immediate resignation of both its Managing…
Read the full analysis - Intimation of Resignation Mr. Kunjan Nathabhai Rathod as Chief Financial Officer.Company Updatemedium impact
Cruxal's analysis: Boston Commerce Limited has formally announced the resignation of its Chief Financial…
Read the full analysis - Intimation of Resignation of Mr. Ghanshyam Dhananjay Gavali as Chairman and Managing Director of the company.Company Updatemedium impact
Cruxal's analysis: Boston Commerce Limited has formally announced the resignation of Mr. Ghanshyam Dhananjay…
Read the full analysis - Boston Commerce Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Intimation of the Board Meeting ....Board Meetinglow impact
Cruxal's analysis: Boston Commerce Limited has formally intimated the BSE regarding a Board of Directors…
Read the full analysis - Submission of Voting Results of EGM held on 5th August 2026AGM/EGMhigh impact
Cruxal's analysis: Boston Commerce Limited held an Extra Ordinary General Meeting on 05th August 2026, where…
Read the full analysis - Submission of Scrutinizer''s Report of EGM held on 5th August 2026.AGM/EGMlow impact
Cruxal's analysis: Boston Commerce Limited has submitted the Scrutinizer's Report following its Extra…
Read the full analysis - Outcome of Extra-Ordinary General Meeting (EGM) held on 5th August 2026AGM/EGMhigh impact
Cruxal's analysis: Boston Commerce Limited held an Extraordinary General Meeting on August 5, 2026, to seek…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Boston Bio Systems Ltd
Cruxal reads every Boston Bio Systems Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.